Periodontal Disease and Other Nontraditional Risk Factors for CKD

American Journal of Kidney Diseases

Volumn 51, Issue 1, 2008, Pages 45-52

  Fisher, Monica A ^a   Taylor, George W ^b   Shelton, Brent J ^c   Jamerson, Kenneth A ^b   Rahman, Mahboob ^a   Ojo, Akinlolu O ^b   Sehgal, Ashwini R ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Chronic kidney disease; diabetes mellitus; edentulism; glomerular filtration rate; hypertension; macroalbuminuria; periodontal disease

Indexed keywords

ADULT; ANTHROPOMETRY; ARTICLE; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEALTH BEHAVIOR; HEALTH CARE FACILITY; HEALTH STATUS; HUMAN; INSTRUMENTATION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERIODONTAL DISEASE; PREVALENCE; RISK FACTOR; SOCIOECONOMICS; UNIVARIATE ANALYSIS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PREVALENCE; RISK FACTORS;

EID: 37349075192     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2007.09.018     Document Type: Article

References (41)

1. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis 39 suppl 1 (2002) S1-S266
2. Centers for Disease Control and Prevention. Prevalence of chronic kidney disease and associated risk factors-United States, 1999-2004. MMWR Morbid Mortal Wkly Rep 56 (2007) 161-165
3. Coresh J., Byrd-Hold D., Astor B.C., et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16 (2005) 180-188
4. Go A., Chertow G., Fan D., McCulloch C.E., and Hsu Cy. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351 (2004) 1296-1305
5. Keith D.S., Nichols G.A., Guillion C.M., Brown J.B., and Smith D.H. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164 (2004) 659-663
6. Rahman M., Pressel S., Davis B.R., et al. Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate. Ann Intern Med 144 (2006) 172-180
7. Bang H., Vupputuri S., Shoham D.A., et al. SCreening for Occult REnal Disease (SCORED): A simple prediction model for chronic kidney disease. Arch Intern Med 167 (2007) 374-381
8. Stevens L.A., Coresh J., Green T., and Levey A.S. Assessing kidney function-Measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
9. Haroun M.K., Jaar B.G., Hoffman S.C., Comstock G.W., Klag M.J., and Coresh J. Risk factors for chronic kidney disease: A prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14 (2003) 2934-2941
10. Sarnak M.J., Levy A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42 (2003) 1050-1065
11. Jamerson K.A. Preventing chronic kidney disease in special populations. Am J Hypertens 18 suppl s (2005) S106-S111
12. Fox C.S., Larson M.G., Leip E.P., Meigs J.B., Wilson P.W.F., and Levy D. Glycemic status and development of kidney disease. Diabetes Care 28 (2005) 2436-2440
13. Norris K.C., and Agodoa L.Y. Unraveling the racial disparities associated with kidney disease. Kidney Int 68 (2005) 914-924
14. Rule A.D., Jacobsen S.J., Schwartz G.L., et al. A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. Am J Hypertens 19 (2006) 608-614
15. Parikh N.I., Hwang S.J., Larson M.G., Meigs J.B., Levy D., and Fox C.S. Cardiovascular disease risk factors in chronic kidney disease. Arch Intern Med 166 (2006) 1884-1891
16. Vupputri S., and Sandler D.P. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 13 (2003) 712-720
17. Cohn J.N., Quyyumi A.A., Hollenberg N.K., and Jamerson K.A. Surrogate markers for cardiovascular disease: Functional markers. Circulation 109 (2004) 31-46
18. Tonelli M., Sacks F., Pfeffer M., Jhangri G.S., and Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68 (2005) 237-245
19. Stenvinkel P. New insights on inflammation in chronic kidney disease-Genetic and non-genetic factors. Nephrol Ther 2 (2006) 111-119
20. Shultis W.A., Weil E.J., Looker H.C., et al. Effect of periodontitis on overt nephropathy and end-stage renal disease in type 2 diabetes. Diabetes Care 30 (2007) 306-311
21. Saremi A., Nelson R.G., Tulloch-Reid M., et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care 28 (2005) 27-32
22. Kshirsagar A.V., Moss K.L., Elter J.R., Beck J.D., Offenbacher S., and Falk R.J. Periodontal disease is associated with renal insufficiency in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 45 (2005) 650-657
23. Feldman H.I., Appel L.J., Chertow G.M., et al. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and method. J Am Soc Nephrol 14 suppl 2 (2003) S148-S153
24. Cazzavillan S., Ratanarat R., Segala C., et al. Inflammation and subclinical infection in chronic kidney disease: A molecular approach. Blood Purif 25 (2007) 69-76
25. Phipps K.R., and Stevens V.J. Relative contribution of caries and periodontal disease in adult tooth loss for an HMO dental population. J Public Health Dent 55 (1995) 250-252
26. Loos B.G. Systemic markers of inflammation in periodontitis. J Periodontol 76 (2005) 2106-2115
27. Offenbacher S., and Beck J.D. A perspective on the potential cardioprotective benefits of periodontal therapy. Am Heart J 149 (2005) 950-954
28. Slade G.D., Offenbacher S., Beck J.D., Heiss G., and Pankow J.S. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79 (2000) 49-57
29. Tonetti M.S., D'Aiuto F., Nibali L., et al. Treatment of periodontitis and endothelial function. N Engl J Med 356 (2007) 911-920
30. Demmer R.T., and Desvarieux M. Periodontal infections and cardiovascular disease: The heart of the matter. J Am Dent Assoc 137 suppl 2 (2006) S14-S20
31. Beck J.D., and Offenbacher S. Systemic effects of periodontitis: Epidemiology of periodontal disease and cardiovascular disease. J Periodontol 76 (2005) 2089-2100
32. Tonelli M., and Pfeffer M.A. Kidney disease and cardiovascular risk. Ann Rev Med 58 (2007) 123-139
33. National Center for Health Statistics. National Health and Nutrition Examination Survey III Documentation, Codebook, and Data Files. http://www.cdc.gov/nchs/about/major/nhanes/datalink.htm#NHANESIII Accessed August 14, 2007
34. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
35. Fisher M.A., Taylor G.W., and Tilashalski K.R. Smokeless tobacco and severe active periodontal disease, NHANES III. J Dent Res 84 (2005) 705-710
36. Pirkle J.L., Flegal K.M., Bernert J.T., Brody D.J., Etzel R.A., and Maurer K.R. Exposure of the U.S. population to environmental tobacco smoke. JAMA 275 (1996) 1233-1240
37. Shah B., Barnwell B., and Bieler G. SUDAAN User's Manual, Release 8.0 (2001), Research Triangle Institute, Research Triangle Park, NC
38. Borrell L.N., and Papapanou P.N. Analytical epidemiology of periodontitis. J Clin Periodontol 32 suppl 6 (2005) S132-S158
39. Fisher M.A., Taylor G.W., Shelton B.J., and Debanne S.M. Sociodemographic characteristics and diabetes predict invalid self-reported non-smoking in a population-based study of U.S. adults. BMC Public Health 7 (2007) 33. http://www.biomedcentral.com/1471-2458/7/33 Accessed November 13, 2007
40. US Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General (1990), US Department of Health and Human Services, Centers for Disease Control and Prevention, Rockville, MD
41. Rahman M., Pressel S., Davis B.R., et al. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic. Arch Intern Med 165 (2005) 936-946